Wells Fargo’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Wells Fargo’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,325	Closed	-$4K	–	6574
2015 Q3	$4K	Hold	1,325	–	–	﹤0.01%	5913
2015 Q2	$5K	Sell	1,325 -600	-31%	-$2.3K	﹤0.01%	6036
2015 Q1	$9K	Hold	1,925	–	–	﹤0.01%	5676
2014 Q4	$12K	Buy	1,925 +1,000	+108%	+$5.85K	﹤0.01%	5569
2014 Q3	$4K	Hold	925	–	–	﹤0.01%	5885
2014 Q2	$7K	Sell	925 -3,504	-79%	-$27.9K	﹤0.01%	5748
2014 Q1	$47K	Buy	+4,429	New	+$63.3K	﹤0.01%	4951

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Wells Fargo's OCRX Position: Q4 2015 in Review

Wells Fargo sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2015, closing a stake of 1,325 shares — an estimated $4K sold.

Wells Fargo first reported a position in OCRX in Q1 2014 and held it in 7 quarters. The position peaked at $47K in Q1 2014. 29 funds tracked by Wall St. Rank hold OCRX as of Q4 2015.

Wells Fargo reported no remaining Ocera Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Wells Fargo sold 1,325 Ocera Therapeutics, Inc. shares in Q4 2015, an estimated $4K.
Wells Fargo first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Wells Fargo's Ocera Therapeutics, Inc. position peaked at $47K in Q1 2014.
29 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2015.

Based on Wells Fargo's 13F filing for Q4 2015, filed 9 Feb 2016.